WATERLOO, ON, Dec. 5, 2015 /CNW/ - Crawford Class Action Services
reports that the Supreme Court of British Columbia has required that
notice of a certified class action against GlaxoSmithKline Inc.
("GlaxoSmithKline") be provided and has confirmed that an opt-in and
opt-out deadline of April 4, 2016 applies for individuals wishing to
participate. The class action was commenced in British Columbia in 2008
against GlaxoSmithKline as the manufacturer of the antidepressant
called Paxil. The lawsuit alleged that ingestion of Paxil during
pregnancy caused cardiovascular birth defects in newborns. The class
action was certified on behalf of a National Class across Canada.
SOURCE Crawford & Company (Canada) Inc.
For further information:
Questions about the Certification of the class action can be answered by visiting www.paxilclassaction.ca or by contacting Crawford Class Action Services at firstname.lastname@example.org or toll free 1-866-640-9989.